efavirenz
UkraineDrugs containing this active substance
-
The drug is used as part of combination therapy to treat infection caused by the human immunodeficiency virus (HIV-1) in adults and children aged 3 years and older.
Form: tablets, film-coated
Active substance Dosage efavirenz 200 mg ATC: J05AG03
Manufacturer: StridePharma Science Limited
-
The drug is used as part of combination therapy to treat infection caused by the human immunodeficiency virus (HIV-1) in adults and children aged 3 years and older.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg ATC: J05AG03
Manufacturer: StridePharma Science Limited
-
Efavirenz, lamivudine and tenofovir disoproxil fumarate is indicated for the treatment of HIV infection (human immunodeficiency virus type 1) in adults and children aged 10 years and older weighing more than 35 kg.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg lamivudine 300 mg tenofovir disoproxil 245 mg ATC: J05AR11
Manufacturer: Macleods Pharmaceuticals Limited
-
This drug is a combination therapy for the treatment of HIV infection (human immunodeficiency virus type 1) in adults and adolescents aged 10 years and older weighing at least 35 kg.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR06
Manufacturer: StridePharma Science Limited
-
The drug is used as part of combination therapy for the treatment of diseases caused by the human immunodeficiency virus (HIV-1) in adults and children weighing 40 kg or more.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg ATC: J05AG03
Manufacturer: San Pharmaceutical Industries Limited
-
The drug is used as a full treatment regimen for human immunodeficiency virus type 1 (HIV-1) infection in adults and children weighing at least 35 kg.
Form: tablets, film-coated
Active substance Dosage efavirenz 400 mg lamivudine 300 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR11
Manufacturer: Hetero Labs Limited
-
The drug is used as part of combination therapy for the treatment of diseases caused by the human immunodeficiency virus (HIV-1) in adults, adolescents, and children weighing 40 kg or more.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg ATC: J05AG03
Manufacturer: Hetero Labs Limited
-
The drug is intended for the treatment of HIV infection (human immunodeficiency virus type 1) in adults aged 18 years and older who are already receiving antiretroviral therapy and have a blood virus level of less than 50 copies/ml.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR06
Manufacturer: Hetero Labs Limited